Technology -
Software - Infrastructure - NYSE - US
$ 9.79
-2.49 %
$ 5.4 B
Market Cap
-75.31
P/E
1. INTRINSIC VALUE
Balance Sheet
UiPath Inc.
| Current Assets | 2.34 B |
| Cash & Short-Term Investments | 1.63 B |
| Receivables | 540 M |
| Other Current Assets | 169 M |
| Non-Current Assets | 527 M |
| Long-Term Investments | 0 |
| PP&E | 99.2 M |
| Other Non-Current Assets | 427 M |
| Current Liabilities | 799 M |
| Accounts Payable | 33.2 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 766 M |
| Non-Current Liabilities | 221 M |
| Long-Term Debt | 74.2 M |
| Other Non-Current Liabilities | 146 M |
EFFICIENCY
Earnings Waterfall
UiPath Inc.
| Revenue | 1.43 B |
| Cost Of Revenue | 247 M |
| Gross Profit | 1.18 B |
| Operating Expenses | 1.35 B |
| Operating Income | -163 M |
| Other Expenses | -88.9 M |
| Net Income | -73.7 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
UiPath Inc.
| Net Income | -73.7 M |
| Depreciation & Amortization | 17.2 M |
| Capital Expenditures | -14.9 M |
| Stock-Based Compensation | 358 M |
| Change in Working Capital | 0 |
| Others | 38.7 M |
| Free Cash Flow | 306 M |
Wall Street Analysts Price Targets
UiPath Inc.
Wall Street analysts predict an average 1-year price target for PATH of $15.4 , with forecasts ranging from
a
low of
$12 to a high of $25 .
PATH Lowest Price Target
Wall Street Target
12 USD
22.57%
PATH Average Price Target
Wall Street Target
15.4 USD
57.76%
PATH Highest Price Target
Wall Street Target
25 USD
155.36%
4. DIVIDEND
ANALYSIS
PATH does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
UiPath Inc.
Sold
0-3 MONTHS
158 K USD 1
3-6 MONTHS
1.8 M USD 2
6-9 MONTHS
1.75 M USD 2
9-12 MONTHS
1.11 M USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
UiPath: This Market Carnage Is A Perfect Time To Buy This Stock Cheaply
UiPath's stock has dropped ~20% since January, presenting a buying opportunity for long-term investors, despite macroeconomic concerns and disappointing Q4 results. UiPath focuses on agentic automation, boasts a large ARR base, and has high gross margins, making it a strong AI investment. The stock is one of few software companies to trade at just ~2x revenue and ~10x FCF.
seekingalpha.com
- 1 week ago
5 High-Quality AI-Infrastructure Stocks to Buy at Lucrative Valuations
Five high-quality AI stocks are currently available on the dip at attractive valuations. These are ANET, PATH, JBL, BWXT and FIVN.
zacks.com
- 3 weeks ago
UiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching UiPath (PATH) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
zacks.com
- 3 weeks ago
Agentic AI Set to Transform Industries in 2025: 4 Stocks to Watch
UiPath, Zoom Communication, NVIDIA and Microsoft are leading the charge in transforming industries with agentic AI advancements in 2025.
zacks.com
- 3 weeks ago
UiPath Stock is Down 50% in a Year: A Potential Buying Opportunity?
With PATH stock having corrected significantly, we assess its current status to decide on the best strategy for the future.
zacks.com
- 3 weeks ago
Think AI's Prospects Are Overblown? Try This Beaten-Down Growth Stock.
Is artificial intelligence a bubble? That's the trillion-dollar question.
fool.com
- 3 weeks ago
UiPath Launches Test Cloud to Bring AI Agents to Software Testing
NEW YORK--(BUSINESS WIRE)--UiPath announced UiPath Test Cloud, a new approach to software testing that uses AI to amplify tester productivity across the testing lifecycle.
businesswire.com
- 3 weeks ago
The Zacks Analyst Blog Byrna, LiveRamp, Dave, Smiths and UiPath
Byrna, LiveRamp, Dave, Smiths and UiPath are included in this Analyst Blog.
zacks.com
- 3 weeks ago
Down More Than 80% From Its High, Is This AI Stock a Buy?
In today's video, I discuss an artificial intelligence stock focused on agentic solutions, its business strategy, growth opportunities, potential risks, and whether investors should not ignore this AI stock.
fool.com
- 4 weeks ago
The Drop In UiPath Stock Unlocks Long-Term Potential
UiPath's ARR is set to hit $1.816B in FY26 (+9% YoY), driven by 98% gross and 110% net retention. Cloud ARR surged past $975M (+50% YoY) as enterprise adoption of AI-driven automation accelerates. Profitability improved with a 32% non-GAAP margin, $328M free cash flow, and $1.7B cash (zero debt).
seekingalpha.com
- 4 weeks ago
Buy 5 Mid and Small Tech Services Stocks With Massive Short-Term Upside
We recommend five small and mid-cap technology services stocks with huge short-term upside price potential. These are: BYRN, RAMP, DAVE, SMGZY, PATH.
zacks.com
- 4 weeks ago
Coronis Health Enhances Healthcare Delivery Systems through UiPath Platform
SYKESVILLE, Md.--(BUSINESS WIRE)--Coronis Health, (Coronis) a leading provider of healthcare revenue cycle management (RCM) solutions, is pleased to announce that it has leveraged the UiPath Platform™ to enhance its healthcare delivery systems. As part of its comprehensive digital transformation strategy, Coronis leverages the UiPath Platform to enhance advanced AI capabilities while ensuring transparency, security, compliance and ethical governance in all automated processes, driving significa.
businesswire.com
- 1 month ago
8. Profile
Summary
UiPath Inc. PATH
COUNTRY
US
INDUSTRY
Software - Infrastructure
MARKET CAP
$ 5.4 B
Dividend Yield
0.00%
Description
UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.
Contact
452 5th Avenue, New York, NY, 10018
https://www.uipath.com
IPO
Date
April 21, 2021
Employees
3868
Officers
Mr. Vijay Khanna
Chief Corporate Development Officer
Mr. Robert B. Patrick
Chief Marketing Officer
Mr. Ashim Gupta
Chief Financial Officer & Chief Operating Officer
Agi Garaba
Chief People Officer
Mr. Brad C. Brubaker J.D.
General Counsel, Chief Legal Officer & Secretary
Hitesh Ramani
Deputy Chief Financial Officer & Chief Accounting Officer
Mr. Raghu Malpani
Chief Technology Officer
Ms. Andreea Baciu
Chief Culture Officer
Mr. Daniel Solomon Dines
Co-Founder, Chief Executive Officer, & Executive Chairman of the Board
Ms. Allise Furlani
Senior Director of Investor Relations